The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Shakirzianova S.R.

GAUZ «Republic clinical neurology center», Kazan, Russia

Diagnosis without borders

Authors:

Shakirzianova S.R.

More about the authors

Journal: Non Nocere. New Therapeutic Journal. 2025;(9): 96‑98

Read: 74 times

Buy for 300₽
Contact the author
Table of contents

To cite this article:

Shakirzianova SR. Diagnosis without borders. Non Nocere. New Therapeutic Journal. 2025;(9):96‑98. (In Russ.)

 
 
ЭндоКард
 
МСФ на ЯМ
Использование инфографики авторами научных работ
Abstract:

What you need to know about cognitive impairment.

Authors:

Shakirzianova S.R.

GAUZ «Republic clinical neurology center», Kazan, Russia

Close metadata

References:

  1. World Health Organization. Global status report on the public health response to dementia. Geneva: WHO Press; 2021. [Accessed September 15, 2025]. https://www.who.int/publications/i/item/9789240033245
  2. Jia L, Du Y, Chu L, et al. COAST Group. Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults aged 60 years or older in China: a cross-sectional study. Lancet Public Health. 2020;5(12):e661–e671. https://doi.org/10.1016/S2468-2667(20)30185-7
  3. Kenne Malaha A, Thébaut C, Achille D, Preux PM, Guerchet M. Costs of Dementia in Low- And Middle-Income Countries: A Systematic Review. J Alzheimers Dis. 2023;91(1):115–128.  https://doi.org/10.3233/JAD-220239
  4. Bogolepova AN, Vasenina EE, Gomzyakova NA, et al. Clinical Guidelines for Cognitive Disorders in Elderly and Older Patients. S.S. Korsakov Journal of Neurology and Psychiatry. 2021;121(10-3):6-137. (In Russ.) https://doi.org/10.17116/jnevro20211211036
  5. Yakhno N.N. Cognitive disorders in a neurological clinic. Neurological journal. 2006;11(Suppl 1):4-12. 
  6. Zakharov VV, Gromova DO, Current approaches to management of patients with mild cognitive impairment. S.S. Korsakov Journal of Neurology and Psychiatry. 2017;117(3):107-112. (In Russ.) https://doi.org/10.17116/jnevro201711731107-112
  7. Katunina EA, Parusova AV, Golovanova IV, Zavadtseva NV. Cognitive impairment in patients with Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;124(11):81-90. (In Russ.) https://doi.org/10.17116/jnevro202412411181
  8. Petrova NN. Comorbidity of depression and dementia: epidemiological, biological and therapeutic aspects. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;124(11):113-121. (In Russ.) https://doi.org/10.17116/jnevro2024124111113
  9. Ngandu T, Lehtisalo J, Solomon A, et al. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial. Lancet. 2015 Jun 6;385(9984):2255–2263. https://doi.org/10.1016/s0140-6736(15)60461-5
  10. Dao E, Barha CK, Zou J, Wei N, Liu-Ambrose T. Prevention of Vascular Contributions to Cognitive Impairment and Dementia: The Role of Physical Activity and Exercise. Stroke. 2024 Apr;55(4):812–821.  https://doi.org/10.1161/STROKEAHA.123.044173
  11. Bangen KJ, Calcetas AT, Thomas KR, et al. Greater accelerometer-measured physical activity is associated with better cognition and cerebrovascular health in older adults. J Int Neuropsychol Soc. 2023 Nov;29(9):859–869.  https://doi.org/10.1017/S1355617723000140
  12. Martynov A.I., Tanashyan M.M., Malyavin A.G.,et al. Resolution of the Expert Council “Possibilities of neuroprotective therapy in patients with arterial hypertension and cognitive disorders”. Therapy. 2023;9(10):148-158.  https://doi.org/10.18565/therapy.2023.10.148-158
  13. Stakhovskaya LV, Shamalov NA, Khasanova DR, et al. Results of a randomized double blind multicenter placebo-controlled, in parallel groups trial of the efficacy and safety of prolonged sequential therapy with mexidol in the acute and early recovery stages of hemispheric ischemic stroke (EPICA). S.S. Korsakov Journal of Neurology and Psychiatry. 2017;117(3-2):55-65. (In Russ., In Engl.) https://doi.org/10.17116/jnevro20171173255-65
  14. Zakharov V.V., Ostroumova O.D., Kochetkov A.I.,et al. International multicenter randomized double-blind placebo-controlled study assessing the efficacy and safety of sequential therapy with Mexidol® and Mexidol® FORTE 250 in patients with chronic brain ischemia (MEMO): subanalysis in patients with arterial hypertension. Therapy. 2023;9(1):145-159.  https://doi.org/10.18565/therapy.2023.1.145-159
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.